Pharma companies must start preparing its NICE submission at the time of making the regulatory subm...
Read moreTopics include our perspectives on an EU commission report on how international reference pricing ca...
Read moreFrom July 2016 NICE will gain decision power by saying yes, no or maybe to cancer drugs entering the...
Read moreThe proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...
Read moreIn this issue is an overview of the future changes to the UK Cancer Drug Fund as well as approaches ...
Read moreNHS England have recently proposed that NICE should take a more direct role in determining which pro...
Read moreNew legislation has enabled AIFA to approve reimbursement for Avastin for off-label usage in the tre...
Read moreThis issue includes topics such as the recent AIFA approval of Avastin for off label use in Wet-AMD ...
Read more